Pharmacology Watch – December 1, 2016
December 1, 2016
View Issues
-
New Research Supports Safety of Receiving Vital Vaccination During Pregnancy
Infants exposed to combined tetanus, diphtheria, and acellular pertussis vaccinations were no more likely to develop structural birth defects, including microcephaly, than offspring of unvaccinated mothers.
-
CDC Calls for Two-shot HPV Regimen
Recent studies have shown if the first shot is administered before age 15, two shots confer immunity.
-
Growing Evidence of Link Between Cognitive Dysfunction, Androgen Deprivation Therapy
The authors suggested androgen deprivation therapy in the treatment of prostate cancer may be associated with an increased risk of dementia.
-
Study: No Connection Between Cranberry Products, Fewer Urinary Tract Infections
The authors concluded that among older women who are nursing home residents, administration of cranberry capsules vs. placebo was of no benefit in preventing bacteriuria plus pyuria over one year.
-
FDA Actions
In this section: The FDA adds warning label to testosterone products, approves new treatment for non-small cell lung cancer, greenlights drug for soft tissue sarcoma patients, and gives its blessing to the so-called 'artificial pancreas.'